Treatment | Page 91 of 465 | SpiritIndia.com

Healthcare :: Web site to provide quality and safety information for patients is unveiled

As health consumers across the country demand better and more detailed information about their physicians and hospitals, Beth Israel Deaconess Medical Center (BIDMC) is stepping up to detail its own performance efforts ranging from the percentage of clinicians who clean their hands to the number of times physicians take the proper steps in treating heart attack patients.

Health :: Bard Peripheral Vascular Renews Commitment to Support Vascular Disease Foundation

The Vascular Disease Foundation (VDF) announced that Bard Peripheral Vascular Inc, a subsidiary of C. R. Bard, Inc., has renewed its commitment as a VDF National Industry Advocate for the next three years and will serve as a member of VDF’s National Corporate Advisory Board.

Skin Cancer :: Major Gift to Rockefeller U. to Help Combat Most Serious Skin Cancers

The Paul Milstein family has donated $5.5 million to create the Milstein Medical Research Program at Rockefeller University. The initial research efforts will be in the area of skin cancer and will be led by Dr. James G. Krueger, D. Martin Carter Professor and head of the Laboratory for Investigative Dermatology at Rockefeller.

Erectile Dysfunction :: Health Canada warns consumers not to use Zencore tabs due to potential health risks

Health Canada is warning consumers not to use Zencore Tabs, a product advertised as a dietary supplement for sexual enhancement, because it contains an undeclared pharmaceutical ingredient similar to the approved drug tadalafil.

Prostate Cancer :: Protein suppresses spread of prostate cancer

A protein whose function is lost in a broad array of cancers normally suppresses the spread of prostate cancer, MIT researchers and colleagues have shown. As a result, testing for loss of the protein, called Protein 4.1B, could help clinicians predict which cancers are likely to spread, or metastasize.

ADHD :: Fewer children but more adults being prescribed ADHD medication

The number of children being prescribed stimulants for Attention Deficit Hyperactivity Disorder (ADHD) in Western Australia continues to fall with almost an 18 per cent reduction over the past two years.

Healthcare :: Chief Medical Officer launches Annual Report, UK

The Chief Medical Officer, Sir Liam Donaldson, published his Annual Report for 2006, On the State of Public Health, in which he reviews key health problems and developments.

Allergy :: New Center Offers One-Stop Care for Allergy and Sinus Sufferers

The prevalence of chronic sinusitis has increased dramatically in the last two decades. Today, 30?40 million Americans have the condition, making it one of the most common chronic diseases in the United States, surpassing even hypertension and diabetes.

Tumor :: A little more PDGF-BB, a little less tumor growth

The formation of new blood vessels (angiogenesis) is essential to provide nutrients to growing tumors.

Depression :: Sanofi obesity pill Acomplia not be used in patients on antidepressants or with depression

The European Medicines Agency (EMEA) recommended contraindicating Acomplia (rimonabant) from sanofi-aventis, in patients with ongoing major depression or who are being treated with antidepressants, because of the risk of psychiatric side effects.